Roflumilast Tablet
Product Images NDC 59651-801

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Roflumilast (NDC 59651-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Roflumilast Fig1)

This appears to be a table of drug interactions or effects, indicating changes in maximum concentration (Cmax) and area under the curve (AUC) due to different medications. It also includes recommendations for adjusting doses or using caution when combining certain drugs. However, the specific drugs and their interactions are not legible due to errors.*

FDA Label Image

Package Label-principal Display Panel (500 mcg (30 Tablet Bottle))

Each tablet of Roflumilast contains 500 mega grams and is distributed by Aurobindo Pharma USA, Inc. The recommended dose for adults is one tablet a day, see package insert for further information. The tablets are made in India and for pharmacy dispensing, the medication guide should be provided separately to each patient. Store the tablets at a controlled room temperature of 20°C to 25°C. The printed document contains dotted lines that should not be printed.*

FDA Label Image

Chemical Structure (Roflumilast Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.